Related Experiment Video
Updated: Aug 4, 2026
07:32
Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles
Published on: August 28, 2015
Phase-transition polymers for drug delivery
1Department of Polymer Science and Engineering, Han Nam University, Taejeon, Korea.
Critical Reviews in Therapeutic Drug Carrier Systems
|October 26, 1999
Summary
Phase-transition polymers change with stimuli like temperature or pH. These smart polymers are key to developing advanced, modulated drug delivery systems for better therapeutic outcomes.
Area of Science:
- Polymer Science
- Materials Science
- Biomedical Engineering
Background:
- Phase-transition polymers exhibit reversible changes in response to external stimuli.
- Stimuli include pH, temperature, light, metabolites, and electric current.
- These properties enable their use in advanced drug delivery systems.
Purpose of the Study:
- To review phase-transition polymers.
- To explore their applications in drug delivery.
- To highlight stimuli-responsive mechanisms for modulated release.
Main Methods:
- Literature review of phase-transition polymers.
- Analysis of stimuli-responsive mechanisms.
- Categorization of applications in drug delivery.
Main Results:
- Identified various classes of phase-transition polymers.
- Detailed their responses to different external stimuli.
- Showcased successful applications in controlled drug release.
Conclusions:
- Phase-transition polymers offer significant potential for advanced drug delivery.
- Stimuli-responsive properties allow for precise control over drug release kinetics.
- Further research can optimize these polymers for targeted and efficient therapies.
Related Concept Videos
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
01:19Modified-Release Drug Delivery Systems: Overview
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
01:23Modified-Release Drug Delivery Systems: Classification
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:11Oral Drug Delivery Systems: Delayed-Release Systems
Delayed-release drug delivery systems are specialized pharmaceutical formulations designed to postpone the release of active compounds until the drug reaches a specific region of the gastrointestinal (GI) tract, typically the intestine. These systems are essential for drugs that may cause gastric irritation, are unstable in acidic environments, or need to exert therapeutic effects locally in the intestinal or colonic regions.The core feature of delayed-release systems is the use of enteric...